This Wednesday morning, Barclays is buying on Amundi. For its part, Jefferies is beginning to cover Verallia on purchase.
Analyst recommendations: Air Liquide, Teleperformance, STMicroelectronics, Sanofi, Amundi, Verallia, Bureau Veritas, Eurofins, Soitec, Arkema, Axa, Scor | Photo credits: AIR LIQUIDE Deutschland GmbH
Amundi : Barclays falls from “line performance” to “outperformance”, but reduces its price target from 77 to 70 euros.
Veralia : Jefferies initiates coverage of the stock on purchase and is targeting 37 euros.
Liquid air : JPMorgan reduces its target price from 185 to 160 euros. Barclays is now targeting 169 euros, against 187 euros previously.
Teleperformance : JPMorgan, still, reduces its price target by 30 euros, to aim for 410.
Desk Veritas : Credit Suisse lowers its target to 26 euros, against 28.5 previously.
Eurofins : the same broker reduced its target price by 2 euros and is now targeting 108 euros.
Soitec : Berenberg lowers its target price from 270 to 260 euros. On the title STMicroelectronicshe reduced his target by 13 euros to aim for 35.
Arkema : Barclays increases its target price from 129 to 131 euros.
Axa : Citigroup is targeting 27 euros, against 30.1 euros previously.
Sanofi : the same office is now targeting 118 euros, against 117.38 euros previously.
score : finally, the broker lowers its target price from 27 to 23.93 euros.
Invest